CRDN Delivers 30 mil increase to stockholder equity over 9 months... Qrtrly report follows!
Ceradyne, Inc. Reports 2003 Third Quarter, Nine-Month Results; Record-Level Results Continue; Margins Rise
COSTA MESA, Calif., Oct 29, 2003 (BUSINESS WIRE) -- Ceradyne, Inc.
(Nasdaq: CRDN) today reported results for the third quarter and nine months ended
September 30, 2003.
Sales for the third quarter 2003 rose 89.1% to a record $27.0 million from $14.3
million in the third quarter of 2002. Net income for the third quarter 2003
increased to a record $3.3 million, or 31 cents per diluted share, on 10,585,000
shares, from $662,000, or 8 cents per diluted share, on 8,769,000 shares, in the
third quarter of 2002.
Gross profit margin increased to 30.2% of net sales in the third quarter of 2003
from 22.7% of net sales in the third quarter of 2002.
The provision for income taxes was 35% for both the third quarter of 2003 and
2002.
Sales for the nine months ended September 30, 2003, reached a record $68.3
million, up 56.7% from $43.6 million in the comparable period last year. Net
income for the first nine months of 2003 increased to $7.0 million, or 74 cents
per diluted share, on 9,437,000 shares, from $1.7 million, or 20 cents per
diluted share, on 8,718,000 shares, for the nine-month period in 2002. The
average number of shares increased due to the Follow-On Offering of 1,725,000
shares that was completed in July 2003. Net income for the nine months ended
September 2003 was up 302.1% over the comparable period last year.
New bookings for the third quarter of 2003 reached a record $52.3 million,
compared to $16.0 million for the same period last year. For the first nine
months of 2003, new bookings increased 128.1% to a record $100.6 million,
compared to $44.1 million for the comparable period last year.
Total backlog as of September 30, 2003, increased to a record $67.7 million
(including $1.1 million of unexercised options), compared to total backlog at
September 30, 2002, of $28.2 million (including $1.4 million of unexercised
options).
Joel P. Moskowitz, Ceradyne president and chief executive officer, commented:
"We are pleased with the significant growth of sales, income, and new orders in
the third quarter. The increase in margins reflects an improved absorption of
fixed operating costs, better operating efficiencies, increased productivity,
and an improved sales mix. Much of the sales and new order increases are
attributable to increasing demand for the Company's body armor for our soldiers.
On September 29, 2003, we announced receipt of a multi-year SAPI body armor
award with 2004 deliveries scheduled at $29 million. This amount was amended
upward by $14.3 million earlier this month to a total scheduled for 2004 of over
$43 million."
Moskowitz further commented: "We have completed the acquisition of an additional
115,000 sq. ft. of manufacturing space in Kentucky which will be used for
production of anticipated new business related to industrial and diesel engine
components produced from Ceradyne's sintered reaction bonded silicon nitride
(SRBSN). The Company anticipates expenditures of $1.6 million to facilitate and
renovate this facility as well as further expenditures for capital equipment."
Ceradyne will host a conference call today at 8:00 a.m. PST to discuss its 2003
third quarter results. Investors or other interested parties may listen to the
teleconference live via the Internet at www.ceradyne.com or
www.Fulldisclosure.com. These Web sites will also host an archive of the
teleconference. A telephonic playback will also be available for 48 hours
beginning at 11:00 a.m. PST on October 29. The playback can be accessed by
calling 800-642-1687 (or 706-645-9291 for international callers) and providing
Conference ID 3331296.
Ceradyne develops, manufactures, and markets advanced technical ceramic products
and components for defense, industrial, automotive/diesel, and commercial
applications. Additional information can be found at the Company's Web site:
www.ceradyne.com.
Except for the historical information contained herein, certain matters
discussed in this news release constitute forward-looking statements that
involve risks and uncertainties that could cause actual results to differ
materially from those projected. The Company may use words such as
"anticipates," "believes," "plans," "expects," "intends," "future," and similar
expressions to identify forward-looking statements. These risks and
uncertainties are described in the Company's prospectus dated July 1, 2003, as
filed with the Securities and Exchange Commission.
Below is a summary of unaudited comparative results. Amounts in
thousands except per share data.
Three Months Ended Nine Months Ended
September 30, September 30,
2003 2002 2003 2002
--------- -------- --------- --------
NET SALES $27,043 $14,300 $68,331 $43,598
Cost of product sales 18,870 11,058 48,947 34,466
--------- -------- --------- --------
GROSS PROFIT 8,173 3,242 19,384 9,132
--------- -------- --------- --------
Operating expenses:
Selling 627 514 1,707 1,504
General and administrative 1,984 1,233 5,489 3,514
Research and development 575 506 1,506 1,537
--------- -------- --------- --------
3,186 2,253 8,702 6,555
--------- -------- --------- --------
INCOME FROM OPERATIONS 4,987 989 10,682 2,577
Other income (expense):
Other income 89 60 164 176
Interest expense (4) (31) (32) (64)
--------- -------- --------- --------
85 29 132 112
INCOME BEFORE PROVISION
FOR INCOME TAXES 5,072 1,018 10,814 2,689
Provision for income taxes 1,775 356 3,785 941
--------- -------- --------- --------
NET INCOME $3,297 $662 $7,029 $1,748
========= ======== ========= ========
Earnings per share, basic $0.32 $0.08 $0.77 $0.21
Earnings per share, diluted $0.31 $0.08 $0.74 $0.20
Avg. shares outstanding, basic 10,324 8,512 9,175 8,475
Avg. shares outstanding, diluted 10,585 8,769 9,437 8,718
Condensed Consolidated Balance Sheets (in thousands):
September 30, December 31,
2003 2002
---------------- ----------------
Cash and Cash Equivalents $28,115 $350
Other Current Assets 40,691 34,773
Net Property, Plant and Equipment 23,168 18,660
Other Assets 1,511 1,511
---------------- ----------------
Total Assets $93,485 $55,294
================ ================
Current Liabilities $12,607 $10,354
Long-Term Debt - 58
Deferred Tax Liability 1,471 1,794
Stockholders' Equity 79,407 43,088
---------------- ----------------
Total Liabilities and
Stockholders' Equity $93,485 $55,294
================ ================
SOURCE: Ceradyne, Inc. |
